ANVS
Annovis Bio Inc
1.20$
+1.7%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2010 | 2011 | 2012 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -24.7% | – | -762.9% | – | – | – | – | – | – | – | – | – | |
| 0.7% | – | 8.0% | – | – | – | – | – | – | – | – | – | |
| 8.1% | – | 4,729.2% | – | – | – | – | – | – | – | – | – | |
| 2.2% | – | 43.0% | – | – | – | – | – | – | – | – | – | |
| -14.3% | – | -44.3% | – | – | – | – | – | – | – | – | – | |
| 94.1% | – | 0.7% | – | – | – | – | – | – | – | – | – | |
| -2.2% | – | 95.3% | – | – | – | – | – | – | – | – | – | |
| 91.9% | – | 96.0% | – | – | – | – | – | – | – | – | – | |
| 60.6% | – | -710.9% | – | – | – | – | – | – | – | – | – |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.